DK1704148T3 - Nye kondenserede pyrrolocarbazoler - Google Patents
Nye kondenserede pyrrolocarbazolerInfo
- Publication number
- DK1704148T3 DK1704148T3 DK04815262.3T DK04815262T DK1704148T3 DK 1704148 T3 DK1704148 T3 DK 1704148T3 DK 04815262 T DK04815262 T DK 04815262T DK 1704148 T3 DK1704148 T3 DK 1704148T3
- Authority
- DK
- Denmark
- Prior art keywords
- new condensed
- condensed pyrrolocarbazoles
- pyrrolocarbazoles
- new
- condensed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53218203P | 2003-12-23 | 2003-12-23 | |
US11/017,947 US7169802B2 (en) | 2003-12-23 | 2004-12-22 | Fused pyrrolocarbazoles |
PCT/US2004/043160 WO2005063763A1 (en) | 2003-12-23 | 2004-12-23 | Novel fused pyrrolocarbazoles |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1704148T3 true DK1704148T3 (da) | 2011-06-14 |
Family
ID=34703676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04815262.3T DK1704148T3 (da) | 2003-12-23 | 2004-12-23 | Nye kondenserede pyrrolocarbazoler |
Country Status (30)
Country | Link |
---|---|
US (4) | US7169802B2 (da) |
EP (1) | EP1704148B1 (da) |
JP (1) | JP5006046B2 (da) |
KR (2) | KR20120066057A (da) |
CN (1) | CN1918162B (da) |
AR (1) | AR047168A1 (da) |
AT (1) | ATE500256T1 (da) |
AU (1) | AU2004309394B2 (da) |
BR (1) | BRPI0418113B8 (da) |
CA (1) | CA2549627C (da) |
CR (1) | CR8519A (da) |
CY (1) | CY1111524T1 (da) |
DE (1) | DE602004031672D1 (da) |
DK (1) | DK1704148T3 (da) |
EA (1) | EA012295B1 (da) |
HK (1) | HK1096096A1 (da) |
HR (1) | HRP20110373T1 (da) |
IL (1) | IL176384A (da) |
IS (1) | IS8519A (da) |
MA (1) | MA28298A1 (da) |
MY (2) | MY143373A (da) |
NO (2) | NO336893B1 (da) |
NZ (1) | NZ548099A (da) |
PL (1) | PL1704148T3 (da) |
PT (1) | PT1704148E (da) |
RS (1) | RS51886B (da) |
SG (1) | SG149045A1 (da) |
SI (1) | SI1704148T1 (da) |
TW (1) | TWI355385B (da) |
WO (1) | WO2005063763A1 (da) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060276497A1 (en) * | 2000-05-09 | 2006-12-07 | Cephalon, Inc. | Novel multicyclic compounds and the use thereof |
US7241779B2 (en) * | 2003-12-23 | 2007-07-10 | Cephalon, Inc. | Fused pyrrolocarbazoles |
SE0401790D0 (sv) * | 2004-07-07 | 2004-07-07 | Forskarpatent I Syd Ab | Tamoxifen response in pre- and postmenopausal breast cancer patients |
EP2064178A4 (en) * | 2006-09-08 | 2011-10-05 | Merck Canada Inc | CATHEPSIN S INHIBITOR PRODRUGS |
US20080125377A1 (en) * | 2006-11-28 | 2008-05-29 | Bartels Stephen P | Delivery system for antiangiogenic and antiinflammatory pharmaceuticals and method of use |
WO2008151323A1 (en) * | 2007-06-08 | 2008-12-11 | University Of Massachusetts | Mixed lineage kinases and metabolic disorders |
TWI580694B (zh) | 2007-11-30 | 2017-05-01 | 建南德克公司 | 抗-vegf抗體 |
UA107652C2 (en) | 2008-10-06 | 2015-02-10 | Incuron Llc | Carbazole compounds and therapeutic uses of the compounds |
AU2009308293B2 (en) | 2008-10-22 | 2015-02-05 | Genentech, Inc. | Modulation of axon degeneration |
EP2367829B1 (en) * | 2008-11-19 | 2013-01-02 | Cephalon, Inc. | Novel forms of an indazolo [5,4-a] pyrrolo [3,4-c] carbazole compound |
EP2192121A1 (en) | 2008-11-27 | 2010-06-02 | Cephalon France | Regioselective reduction of fused pyrrolocarbazoles-5,7-diones |
CN102325755B (zh) * | 2008-12-30 | 2015-07-01 | 艾科尔公司 | 取代的5,6-二氢-6-苯基苯并[f]异喹啉-2-胺化合物 |
AU2009335016A1 (en) * | 2008-12-30 | 2011-08-18 | Arqule, Inc. | Substituted pyrazolo [3, 4-b] pyridine compounds |
US20120328609A1 (en) * | 2009-10-22 | 2012-12-27 | Genentech, Inc. | Modulation of Axon Degeneration |
US20110189174A1 (en) | 2010-02-01 | 2011-08-04 | Afshin Shafiee | Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization |
MX2012013304A (es) * | 2010-05-18 | 2013-04-03 | Cephalon France | Metodo para purificar un derivado de pirrolocarbazol fusionado. |
CN103664797A (zh) * | 2012-09-25 | 2014-03-26 | 杨子娇 | 一类治疗房角狭窄的化合物及其用途 |
CN104370880A (zh) * | 2013-01-24 | 2015-02-25 | 韩冰 | 一类蛋白酶抑制剂及其制备方法和用途 |
WO2014124454A1 (en) | 2013-02-11 | 2014-08-14 | Katerina Gurova | Use of facilitates chromatin transcription complex (fact) in cancer |
JP2016536350A (ja) * | 2013-09-26 | 2016-11-24 | シーエイチディーアイ ファウンデーション,インコーポレーテッド | キヌレニン−3−モノオキシゲナーゼ阻害薬、医薬組成物、及びこれらの使用方法 |
CN106572992A (zh) | 2014-04-06 | 2017-04-19 | 英丘伦有限责任公司 | 用curaxins进行组合治疗 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ245203A (en) | 1991-11-29 | 1997-07-27 | Banyu Pharma Co Ltd | 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates |
US5475110A (en) | 1994-10-14 | 1995-12-12 | Cephalon, Inc. | Fused Pyrrolocarbazoles |
US5594009A (en) | 1994-10-14 | 1997-01-14 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US5705511A (en) | 1994-10-14 | 1998-01-06 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US5591855A (en) | 1994-10-14 | 1997-01-07 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US5616724A (en) | 1996-02-21 | 1997-04-01 | Cephalon, Inc. | Fused pyrrolo[2,3-c]carbazole-6-ones |
KR100450034B1 (ko) | 1996-08-22 | 2004-09-24 | 브리스톨-마이어즈 스퀴브 컴페니 | 세포독성 아미노당 및 인돌로피롤로카바졸과 관련된 당 유도체 |
US6841567B1 (en) | 1999-02-12 | 2005-01-11 | Cephalon, Inc. | Cyclic substituted fused pyrrolocarbazoles and isoindolones |
US6399780B1 (en) | 1999-08-20 | 2002-06-04 | Cephalon, Inc. | Isomeric fused pyrrolocarbazoles and isoindolones |
US6630500B2 (en) | 2000-08-25 | 2003-10-07 | Cephalon, Inc. | Selected fused pyrrolocarbazoles |
AU2001292579A1 (en) * | 2000-09-29 | 2002-04-15 | Eli Lilly And Company | Methods and compounds for treating proliferative diseases |
US6653290B2 (en) | 2000-10-06 | 2003-11-25 | Bristol-Myers Squibb Company | Tumor proliferation inhibitors |
US6610727B2 (en) | 2000-10-06 | 2003-08-26 | Bristol-Myers Squibb Company | Anhydro sugar derivatives of indolocarbazoles |
AR035971A1 (es) | 2001-05-16 | 2004-07-28 | Cephalon Inc | Metodos para el tratamiento y la prevencion del dolor |
US7241779B2 (en) * | 2003-12-23 | 2007-07-10 | Cephalon, Inc. | Fused pyrrolocarbazoles |
-
2004
- 2004-12-22 US US11/017,947 patent/US7169802B2/en active Active
- 2004-12-23 JP JP2006547322A patent/JP5006046B2/ja active Active
- 2004-12-23 DE DE602004031672T patent/DE602004031672D1/de active Active
- 2004-12-23 KR KR1020127011232A patent/KR20120066057A/ko not_active Application Discontinuation
- 2004-12-23 CN CN200480041770.5A patent/CN1918162B/zh active Active
- 2004-12-23 KR KR1020067014792A patent/KR101179372B1/ko active IP Right Grant
- 2004-12-23 NZ NZ548099A patent/NZ548099A/en not_active IP Right Cessation
- 2004-12-23 AT AT04815262T patent/ATE500256T1/de active
- 2004-12-23 CA CA2549627A patent/CA2549627C/en active Active
- 2004-12-23 WO PCT/US2004/043160 patent/WO2005063763A1/en active Application Filing
- 2004-12-23 PT PT04815262T patent/PT1704148E/pt unknown
- 2004-12-23 AU AU2004309394A patent/AU2004309394B2/en active Active
- 2004-12-23 RS RS20110203A patent/RS51886B/en unknown
- 2004-12-23 DK DK04815262.3T patent/DK1704148T3/da active
- 2004-12-23 SG SG200809413-8A patent/SG149045A1/en unknown
- 2004-12-23 PL PL04815262T patent/PL1704148T3/pl unknown
- 2004-12-23 SI SI200431670T patent/SI1704148T1/sl unknown
- 2004-12-23 BR BRPI0418113A patent/BRPI0418113B8/pt active IP Right Grant
- 2004-12-23 EA EA200601217A patent/EA012295B1/ru not_active IP Right Cessation
- 2004-12-23 EP EP04815262A patent/EP1704148B1/en active Active
- 2004-12-23 TW TW093140222A patent/TWI355385B/zh not_active IP Right Cessation
- 2004-12-23 MY MYPI20045332A patent/MY143373A/en unknown
- 2004-12-23 MY MYPI20093362A patent/MY158159A/en unknown
- 2004-12-27 AR ARP040104890A patent/AR047168A1/es not_active Application Discontinuation
-
2006
- 2006-06-18 IL IL176384A patent/IL176384A/en active IP Right Grant
- 2006-06-22 IS IS8519A patent/IS8519A/xx unknown
- 2006-06-29 US US11/477,639 patent/US7671064B2/en active Active
- 2006-07-10 NO NO20063196A patent/NO336893B1/no not_active IP Right Cessation
- 2006-07-17 MA MA29192A patent/MA28298A1/fr unknown
- 2006-07-19 CR CR8519A patent/CR8519A/es unknown
-
2007
- 2007-03-27 HK HK07103232.5A patent/HK1096096A1/xx unknown
-
2010
- 2010-02-18 US US12/708,306 patent/US8044064B2/en active Active
-
2011
- 2011-05-19 HR HR20110373T patent/HRP20110373T1/hr unknown
- 2011-06-01 CY CY20111100533T patent/CY1111524T1/el unknown
- 2011-09-16 US US13/234,501 patent/US8383813B2/en active Active
-
2015
- 2015-09-23 NO NO20151245A patent/NO20151245A1/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054005D0 (no) | Nye arylpiperazinylforbindelser | |
NO20055219D0 (no) | Nye forbindelser | |
NO20054224D0 (no) | Nye 2-pyridinkarboksamidderivater | |
NO20044588L (no) | Nye forbindelser | |
NO20044432L (no) | Nye forbindelser | |
ATE363383T1 (de) | Schlingenware | |
DK1704148T3 (da) | Nye kondenserede pyrrolocarbazoler | |
DE602004009385D1 (de) | Spurhaltevorrichtung | |
AT502792A5 (de) | Düsenanpressvorrichtung | |
ATA662003A (de) | Trink-mundstück | |
NO20054172D0 (no) | Nye blandinger | |
ATE446959T1 (de) | Chromenonindole | |
DE502004001629D1 (de) | Bremsenprüfstand | |
DE502004005544D1 (de) | Mikrodosiereinrichtung | |
NO20030752D0 (no) | Bölgedempningsanordning | |
ATE444953T1 (de) | Substituierte spirobenzazepine | |
DE60330070D1 (de) | Tracking-einrichtung | |
DE602004010064D1 (de) | Freilaufkupplungsfeder | |
NO20044098L (no) | Nye forbindelser | |
NO20053717D0 (no) | Stottefjaer | |
ATE406350T1 (de) | Prolinylarylacetamide | |
NO20050026L (no) | Nye benzodioksoler | |
DE10316511B4 (de) | Teigportionierer | |
NO20035480L (no) | Hurtigskjot | |
ATA80232004A (de) | Kurbelgehäuse |